Abstract
Immunotherapy, a promising cancer treatment method, faces challenges such as off-target effects and limited efficacy. Researchers are utilizing nanotechnology to enhance the accuracy and effectiveness of immunotherapy. In a clinical trial, nanoparticles were used to directly carry immunomodulatory drugs to tumor locations, enhancing cytotoxic T cell activation and preventing tumor growth. Patients receiving nanoparticle-enhanced immunotherapy experienced longer progression-free survival times and higher response rates than those receiving standard immunotherapy alone. This study demonstrates how nanotechnology is revolutionizing immunotherapy approaches for focused cancer treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: i-manager’s Journal on Future Engineering and Technology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
